CTLA4 and pneumonitis: One meta-analysis on clinical trials of ICI agents (PD-1, PD-L1, and CTLA-4) from 2003–2015 found that pneumonitis was more likely to occur in NSCLC and renal cell carcinoma as compared to melanoma.42